Both transwell and migration assays showed that NPTX2 overexpression markedly promoted tumor cell invasion and migration, while these promoting effects were also reversed after IL-6-neutralizing antibody treatment (Figures 5D, E). The gene discussed is IL6; the disease is neoplasm.